ATM Founder Presents at Harvard Medical School

“Together with all stakeholders we should define the role of the pharmaceutical industry in developing countries, measuring their efforts and activities on the path towards improving access to medicines. Every company, every other year.”

Wim Leereveld, Chairman and Founder of the Access to Medicine Foundation, was recently invited to present at the Drug Policy Research Group and WHO Collaborating Center in the Pharmaceutical Policy Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care.

In the audience were faculty and graduate students in health policy and related fields at Harvard, Boston, Tufts, and Northeastern Universities. The session, entitled: Harvard Pharmaceutical Policy Research Seminar was also linked via video to policy researchers in the National Public Health Institute in Mexico.
To download the presentation press here